Max Healthcare Institute Ltd
Max Healthcare Institute Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management said on revenue, margins and capex.
Guidance rank: #27 of 32 in Healthcare Services
See the sector's top 10 — free with your mobile number.
What the Q1 FY27 call signalled
2 of 4 strong
The short version
Continued capacity expansion across key locations (Lucknow, Noida, Nagpur) leading to higher occupancy and revenue growth. Revenue growth momentum remains strong with 16% year-on-year growth in Q1 FY27.
From Max Healthcare Institute Ltd's Q1 FY27 earnings-call transcript · updated 23 Sept 2026.
Revenue & Sales Performance
- Continued capacity expansion across key locations (Lucknow, Noida, Nagpur) leading to higher occupancy and revenue growth.
- New brownfield capacity additions expected to contribute directly to bottom-line profitability.
- Incremental beds being added at Nanavati and Max Smart, with occupancy ramping up to around 80%, suggesting strong revenue and EBITDA growth potential.
- Commissioning of new hospital beds phased over quarters, with EBITDA impact expected from Q2-Q3 onward.
- Long-term outlook supports steady ARPOB growth of 7-8%, outpacing inflation due to innovation and novel treatments.
- Institutional revenue share expected to decline gradually due to changing mix.
2 more points from Max Healthcare Institute Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Max Healthcare Institute Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Approved capex of INR 425 crore for a new brownfield tower at Max Vaishali adding 202 beds; construction started, commissioning expected before FY30.
- Ongoing capacity expansions include:
- 100 beds at Max Lucknow (commissioning next two quarters)
- 500 beds at Sector 56 Gurgaon (phased commissioning from end of this year)
- 250 beds at Bhubaneswar (renovations to complete within 12 months)
- 100 beds at Nagpur (commissioning by FY28)
- 400 beds at Zirakpur, Mohali (commissioning in FY28)
- Onco day care block at Max Dwarka (awaiting occupancy certificate)
- 260 beds at Dwarka (commission by FY30)
- 200 beds at Pitampura (commission by FY29)
- 400 beds at Patparganj (work started, commissioning by end FY29)
- 271 beds at Nanavati Phase 2 (commission by FY30)
2 more points from Max Healthcare Institute Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Max Healthcare Institute Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Max Healthcare Institute Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹2.6K Cr, net profit ₹414 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Max Healthcare's management said in earlier quarters
- Q2 FY27 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q3 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
- Q4 FY23 earnings call →
Others in Healthcare Services this season
- Aatmaj Health (Q1 FY27)
Revenue for Q1 FY 2026-27: ₹8.13 crore . Key investor presentation takeaways from Aatmaj Healthcare Ltd's Q1 FY27 investor presentation — and how it ranks again
- Asarfi Hospital Ltd (Q1 FY27)
Q1'FY27 consolidated revenue from operations: ₹47.5 Cr, up 32.8% YoY (vs ₹35.7 Cr in Q1'FY26) . Key investor presentation takeaways from Asarfi Hospital Ltd's Q
- KMC Speciality (Q1 FY27)
Q1 FY'27 Revenue from operations: INR 91.8 Cr, up 38% YoY from INR 66.6 Cr in Q1 FY'26. Key concall takeaways from KMC Speciality Hospitals (India) Ltd's Q1…
- 3B Blackbio (Q1 FY27)
Q1 2026-27 revenue from operations: ₹3,205.73 Lakh (including Coris sales of ₹862.83 Lakh) vs ₹1,996.06 Lakh in Q1 2025-26 — YoY growth approx. Key concall…
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- Aster DM Quality Care LtdGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Max Healthcare Institute Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Max Healthcare Institute Ltd Q1 FY27 results?
Continued capacity expansion across key locations (Lucknow, Noida, Nagpur) leading to higher occupancy and revenue growth. Revenue growth momentum remains strong with 16% year-on-year growth in Q1 FY27.
What is Max Healthcare Institute Ltd share price analysis?
Max Healthcare Institute Ltd currently shows a below-average growth signal. The stock trades at a P/E of 68.2 with a market cap of ₹102,129 Cr. Investors should review the full earnings analysis for detailed insights.
Is Max Healthcare Institute Ltd planning capital expenditure?
Approved capex of INR 425 crore for a new brownfield tower at Max Vaishali adding 202 beds; construction started, commissioning expected before FY30.
Keep Max Healthcare Institute Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
